Dual-listed respiratory company Fisher & Paykel Healthcare (FPH) says its FY26 results will include a 50 basis point impact from US tariffs on hospital products from New Zealand.
There was no impact on the annual financial result to the end of March this year, announced today.
Some 60% of the
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
